Detalles de la búsqueda
1.
Effectiveness and cost-effectiveness of erlotinib versus gefitinib in first-line treatment of epidermal growth factor receptor-activating mutation-positive non-small-cell lung cancer patients in Hong Kong.
Hong Kong Med J;
20(3): 178-86, 2014 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-24281768
2.
Robotic hysterectomy compared with laparoscopic hysterectomy: is it still more costly to perform?
J Robot Surg;
16(3): 537-541, 2022 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-34232449
3.
Pursuing Elimination of Hepatitis C in Egypt: Cost-Effectiveness and Economic Evaluation of a Country-Wide Program.
Infect Dis Ther;
11(3): 1193-1203, 2022 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-35451742
4.
Nutrition-Focused Care for Community-Living Adults: Healthcare Utilization and Economic Benefits.
Value Health Reg Issues;
32: 70-77, 2022 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-36099802
5.
Budget Impact Analysis of a Home-Based Nutrition Program for Adults at Risk for Malnutrition.
Am Health Drug Benefits;
13(3): 95-101, 2020 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-32699570
6.
Cost of ownership assessment for a da Vinci robot based on US real-world data.
Int J Med Robot;
15(5): e2023, 2019 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-31215714
7.
Event simulation and external validation applied in published health economic models for obesity: a systematic review.
Expert Rev Pharmacoecon Outcomes Res;
18(5): 529-541, 2018 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-30011385
8.
Budget Impact of a Comprehensive Nutrition-Focused Quality Improvement Program for Malnourished Hospitalized Patients.
Am Health Drug Benefits;
10(5): 262-270, 2017 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-28975010
9.
Systematic review and overview of health economic evaluation models in obesity prevention and therapy.
Expert Rev Pharmacoecon Outcomes Res;
16(5): 561-570, 2016 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-27570095
10.
Early health economic evaluation of the future potential of next generation artificial vision systems for treating blindness in Germany.
Health Econ Rev;
4(1): 27, 2014 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-26208927
11.
Cost comparison of second-line treatment options for late stage non-small-cell lung cancer: cost analysis for Italy.
Clinicoecon Outcomes Res;
4: 237-43, 2012.
Artículo
en Inglés
| MEDLINE | ID: mdl-22969300
Resultados
1 -
11
de 11
1
Próxima >
>>